Azacitidine 100 Mg Injection

Azacitidine 100 Mg Injection Specification

Life Span
24 months

Dosage Form
Injection

Pacakaging (Quantity Per Box)
1 vial

Packaging Type
Vial

Salt Composition
Azacitidine

Indication
Treatment of myelodysplastic syndrome, blood cancer

Origin of Medicine
India

Brand Name
Azatend

Drug Type
Allopathic

Ingredients
Azacitidine

Physical Form
Injection

Function
Anticancer medication

Recommended For
Blood cancer, Myelodysplastic syndrome

Dosage
As prescribed by physician

Dosage Guidelines
Follow doctors instructions

Suitable For
Adults

Quantity
100 mg

Storage Instructions
Store below 30C

ATC Code
L01BC07

Therapeutic Class
Antineoplastic agent

Administration Route
IV or subcutaneous

Strength
100 mg/vial

Appearance
Lyophilized powder

Prescription Status
Prescription only

Reconstitution Required
Yes

Azacitidine 100 Mg Injection Trade Information

Minimum Order Quantity
1 Vial

Supply Ability
5000 Vials Per Month

Delivery Time
2-10 Days

About Azacitidine 100 Mg Injection

Experience the latest breakthrough in cancer treatment with Azatend Azacitidine 100 Mg Injection. This excellent antineoplastic agent offers phenomenal efficacy for adults, specifically indicated for blood cancer and myelodysplastic syndromes. Each vial contains lyophilized powder for reconstitution and is administered either intravenously or subcutaneously under prescription. With world-class quality verified under strict conditions, Azatend ensures instant savings with every offer. Store below 30C for optimal efficacy. Exported, supplied, and traded widely from India, this allopathic formulation is a trusted solution for healthcare providers worldwide.

Versatile Applications and Advanced Features

Azacitidine 100 Mg Injection stands out with its broader impact, extending beyond primary cancer treatment. It possesses world-class versatility and is sometimes explored in research for plant applications and investigational uses. The injection's lyophilized format ensures stability and ease of reconstitution. Additional features include its long shelf-life (24 months), secure vials, excellent export packaging, and compliance with international quality standards. These attributes make it a first-choice option for healthcare institutions and pharmaceutical distributors.

Sample Availability and Nationwide Supply

Azatend Azacitidine 100 Mg Injection is readily available for sampling, allowing healthcare professionals to evaluate its phenomenal effectiveness firsthand. With quick dispatch services and secure shipping, clients across India's main domestic markets enjoy prompt deliveries at the lowest prices. Our robust supply ability guarantees uninterrupted availability, ensuring hospitals, clinics, and wholesalers always have access to this essential medication. Comprehensive, safe packaging ensures the product arrives in excellent condition every time.

FAQ's of Azacitidine 100 Mg Injection:

Q: How is Azacitidine 100 Mg Injection administered?

A: Azacitidine 100 Mg Injection can be administered either intravenously (IV) or subcutaneously as prescribed by a qualified physician.

Q: What conditions is Azacitidine 100 Mg Injection recommended for?

A: It is indicated for the treatment of blood cancer and myelodysplastic syndromes, delivering effective antineoplastic action.

Q: When should Azatend Azacitidine 100 Mg Injection be used?

A: This medication should be used only upon recommendation and prescription from a healthcare provider, following a confirmed diagnosis and dosage instructions.

Q: Where should Azacitidine 100 Mg Injection be stored?

A: Store the injection vial below 30C and protect it from direct sunlight to maintain its efficacy and shelf life.

Q: What is the process for reconstituting Azacitidine Injection?

A: Reconstitution should be performed by trained healthcare professionals following the guidelines provided with the vial, using the appropriate diluent before administration.

Q: What are the main benefits of Azacitidine 100 Mg Injection for patients?

A: Patients benefit from its excellent efficacy in reducing disease progression and improving blood cell formation in myelodysplastic syndrome and certain blood cancers.

Tell us about your requirement